Etude 3000 ARTHROSES Symptomatic Knee and Hip Osteoarthritis Prevalence Survey
NCT ID: NCT01400529
Last Updated: 2011-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3000 participants
OBSERVATIONAL
2007-03-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism
NCT03076866
A Population-based Cohort of Osteoarthritis: the Tsinghua University Tiantongyuan Community Osteoarthritis Study
NCT07006701
The Osteoarthritis Prevention Study
NCT05946044
IDENTIFICATION OF BIOMARKERS ASSOCIATED WITH THE SEVERITY AND RADIO-CLINICAL PROGRESSION OF KNEE OSTEOARTHRITIS
NCT06600958
Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid Arthritis
NCT03005925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There is a substantial lack of information about osteoarthritis (OA) epidemiology in France, as well as in other European countries, which becomes more and more critical with population aging. The need for additional knowledge was outlined in the law about public health priorities in France, published on August 9th, 2004. In this document, a specific call is made for additional investigation on functional limitations, disability and quality of life modification of people affected by OA.
Up to now, available information is mainly limited to short- or medium-term studies, conducted in clinic-based samples. Thus, based on demography and public health conclusions, implementing population-based epidemiologic studies is required in order to improve scientific knowledge with regards to :
* prevalence of symptomatic OA,
* its natural history over years and potential prognostic factors influencing the disease,
* its impact in terms of quality of life changes, disability, lack of autonomy and health resource use.
Our expert group, which has a substantial experience in osteoarthritis, epidemiology and health service research, has developed a 2-part research program aiming to help answering to OA-related public health questions:
* Part 1: a nationwide descriptive epidemiology survey aiming to determine lower limb OA prevalence, based on a validated method previously used to assess inflammatory rheumatism (rheumatoid arthritis and spondylarthropathy) prevalence in France.
* Part 2: the constitution of a population-based cohort of OA patients, aiming to collect clinical, biologic and radiological data about OA natural history, predictors of structural progression, consequences on quality of life, function and health resource use.
The present study is the part 1 of the program
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adults in households representative of the French population for age, sex, area of living and number of household members.
40 Months
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Hospital, Nancy, France
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francis Guillemin, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Societe Francaise de Rhumatologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Rhumatologie. CHU d'Amiens
Amiens, , France
Service de Rhumatologie. CHU de la Cavale Blanche
Brest, , France
Centre d'Epidémiologie Clinique. Service de rhumatologie. CHU Nancy
Nancy, , France
Service de Rhumatologie. CHU L'Archet 1
Nice, , France
Service de Rhumatologie. Hôpital de la Pitié-Salpêtrière
Paris, , France
Service de Rhumatologie. Hôpital Rangueil
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Guillemin F, Rat AC, Mazieres B, Pouchot J, Fautrel B, Euller-Ziegler L, Fardellone P, Morvan J, Roux CH, Verrouil E, Saraux A, Coste J; 3000 Osteoarthritis group. Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey. Osteoarthritis Cartilage. 2011 Nov;19(11):1314-22. doi: 10.1016/j.joca.2011.08.004. Epub 2011 Aug 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
906297
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.